Delivery Order SPE2DR25D2014-SPE2DR26FA4B2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,948.54 on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $15,296.82 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This award represents a child contract under the company's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg, with a ceiling value of $1,849.39. This firm fixed-price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order serves as a child contract under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $8,502.75 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-count units) on January 20, 2026, with a completion date of January 21, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.42 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-unit quantity) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price contract, which involves no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets valued at $14,709.30 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,139.22 to AmerisourceBergen Drug Corp for 27mg Concerta ER tablets on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency. The pharmaceutical products will be delivered to the vendor's...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 28, 2026, valued at $4,293.05 for the supply of Concerta ER 36 mg tablets (100-count units). This firm fixed-price, non-set-aside contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a contract value of $6,339.04. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,273.54 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA4B2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,444.23 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 30, 2026, and will be performed at the awardee's Conshohocken, Pennsylvania location. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 31, 2031, which supports military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company supplies a broad portfolio of prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a child entity under Cencora, Inc., AmerisourceBergen leverages its parent organization's extensive DLA relationship to fulfill varied federal medical supply requirements through competitive, open-market contracting. This delivery order for Concerta ER—a controlled-release methylphenidate formulation used for attention deficit hyperactivity disorder treatment—represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 1/28/26 |